Avalo Therapeutics (AVTX) EBT Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -468,754.00 |
| Dec 31, 2024 | -1.69 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Dec 31, 2023 | -33,785.00 |
| Sep 30, 2023 | -223,325.00 |
| Jun 30, 2023 | -1,637.00 |
| Mar 31, 2023 | -21,499.00 |
| Dec 31, 2022 | 764,873.00 |
| Sep 30, 2022 | 131,494.00 |
| Jun 30, 2022 | -73,890.00 |
| Mar 31, 2022 | 458,241.00 |
| Dec 31, 2021 | -765,221.00 |
| Sep 30, 2021 | -10,022.00 |
| Jun 30, 2021 | 47,470.00 |
| Mar 31, 2021 | -557,873.00 |
| Dec 31, 2020 | -11,636.00 |
| Sep 30, 2020 | -106,574.00 |
| Jun 30, 2020 | -81,359.00 |
| Mar 31, 2020 | -68,749.00 |
| Dec 31, 2019 | -98,895.00 |
| Sep 30, 2019 | 47,491.00 |
| Jun 30, 2019 | -5,374.00 |
| Mar 31, 2019 | -10,921.00 |
| Dec 31, 2018 | 24,249.00 |
| Sep 30, 2018 | -69,018.00 |
| Jun 30, 2018 | 101,454.00 |
| Mar 31, 2018 | 42,422.00 |
| Dec 31, 2017 | 67,249.00 |
| Sep 30, 2017 | 200,642.00 |
| Jun 30, 2017 | -58,400.00 |